The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Need a good PR, sorry
https://www.grid.news/story/science/2022/10/25/childrens-hospitals-are-overwhelmed-by-an-early-respiratory-virus-season-their-troubles-may-just-be-starting/
Sorry for crashing the party but thought it may be important. We a good PR company to promote Synairgen.
Mani - Your use of the term Long Covid is rather muddled it is not clear from what you write if you are suggesting SNG will treat LC or prevent LC.
Your use of Covid/COPD/LC in a statement is also very muddled.
Let’s be clear we stimulate the immune response to treat Viral infections and may exhibit antibacterial properties. These infections are Covid, Influenza etc etc broad spectrum antiviral.
The cohort of patients that may benefit from these actions are the Gen pop but specifically those who suffer with COPD, genetic deficiencies and probably now LC sufferers with lasting damage to their lungs.
We do not directly treat COPD or LC.
When you talk about future LC trials let’s be clear you are talking about Covid trials which may monitor for LC development or generic multi viral trials that may also monitor for ME or Lc like after effects.
I very much doubt you are suggesting we are put on a trial to attempt to treat LC the science to support this is not there.
"No one has suggested that LC is the main focus..."
and yet your postings would offer a different perspective. Even suggesting EUA from the LC results a couple of times.
"As I keep saying... LC is our key asset now..... JV on the cards... In weeks not months...IMHO!
The prospect of a Long Covid trial for SNG looks increasingly likely, and should we release further positive data before our presentation on Friday then an EUA is starting to look plausible...
I am more interested in what influential people/BP think about our LC potential..
LC is now being widely discussed and it is acknowledged there are no treatments currently..
I trust and hope SNG Board are on the same page...We need "haste" let's hope they are doing overtime on this.. ATB!
Yes Prion..... LC could be our USP... it
seems from the AGM that the board know our LC results are significant/ game changing....
If there is further positive data then I wonder if they could make a case for an EUA..
I have posted many times that I think LC results will be our game changer...That will
play out in the next few weeks IMHO.… LC will change our fortunes... There you have it..…
LC potential is going to be a game changer for SNG in 2022..
I am sticking my neck out on this one.....
Doc.Dan
Seriously can you not understand plain english... I reported in my second post of the day
a response from Brooke.. why not go and have a look, then come back and apologise?
Results are not complete, when they are they will be submitted for Peer Review...Get a life !
No one has suggested that LC is the main focus...It is a significant result from SPRINTER...
One that there is clearly interest in and LC is widely discussed now by the Medical community..
I think it may well help to open doors for SNG as part of an impressive data bank from our Trials.
Any Pharma interested in a JV with SNG will look at our potential in many areas that is
what makes us a potential partner.....
Ghia and DOC.Dan are hijacking a topic and diverting the narrative....
As was reported from the AGM there was notable excitement when LC was discussed.
Now SNG are proactively bringing the results to the BP sector...
We have identified several areas SNG001 could be an effective treatment.
Covid/COPD/LC .. I Trust the arrows RM & CO are firing are testing out
all possibilites.... LC is one of them.... One that is currently the talk of
many in the medical community...
Look forward to the Full analysis when available and the presentation
due on our website this week..
Thanks, Ghia.
Is there a consensus on whether they will need a fund raise in 12 months?
you told us they didn't have the "full analysis " Mani - straight from the horses mouth - so the peer review hasn't been submitted.
Anyway I'll let it pass - I'm just about to email Brooke to ask how many Synairgen staff flew to the US to attend PM's 10 minute presentation. How many constitute "huge" I wonder.
The IDWeek presentation will be published on Synairgen's website in due course.
He never happy Manny, maybe he secretly lust after you!
I was very worried for your welfare Manny after your embarrassing week.
Doc.Dan
WE ARE HAVING THE LONG COVID RESULTS PEER REVIEWED YOU SHOULD KNOW THAT BECAUSE IT IS IN A RNS
NOT MY OPINION.....JEEPERS YOU ARE SOUNDING A TAD DERANGED NOW..HERE I WILL POST FROM THE RNS..
The full analysis, including several patient-reported outcome measures, which is ongoing, will be presented in October at IDWeek 2022 and submitted for publication in a peer-reviewed journal.
HAPPY NOW??
Fruits - No I doubt there would be agreement on that.
some of us said this as soon as Mani and Tommyd started banging the alternate pathway drum. Weeks ago. If RM has confirmed recently that the company are still fully focused on Covid it's the very least he should be saying. Everyhting else is cherries or sprinkles on the Covid cake and only becomes the main event if the company fail to convice the people they need to convince that there's merit in a further covid trial for SNG in hospitals.
Do the Guild have a rough / expected timeframe Ghia?
Aether - On the whole optimistic but under no illusion that it will happen overnight.
Ghia
What's the consensus in the guild about the prospects of SNG being commercialised now?
Wigster - I think the key is SNG will likely prevent LC because it reduces the chance of the immune system being overwhelmed and the virus entering other areas of the body.
The key point is it’s the antiviral action and it’s ability to stimulate the immune system that’s the USP.
Long Covid may or may not be a thing with the current and future variants and existing sufferers are likely to have a multitude of causes and symptoms etc.
To target LC is foolish it’s the broad spectrum antiviral properties they need to prove out which may have knock effects to long covid which might add a premium to the ticket but it’s not the silver bullet, hence the sideshow comment.
" We are having our LC results Peer Reviewed....." is what you said Mani
not the same as your little adjustment that we "intend to have etc ...."
I'm amazed frankly - after such a shocking and embarrassing week last week, you took some time off at the weekend but then come blasting right back with more unsupported rampy junk. You're not Liz Truss are you ?
Mani - Academics exist to generate publications. Publications require peer reviews.
I’m not sure why you beat the peer review drum so loudly, it’s part of the scientific research process.
Ghia - many thanks for the guild info.
I agree that it's highly unlikely that LC will prove to be the be-all and end-all for Synairgen, but it will most certainly be a useful chapter in the "formidable portfolio of positive information" which will make Synairgen/SNG001 irresistable for a takeover by a BP / commercialisation.
We have applied for a Peer Review of SPRINTER....
We also intend to get our completed LC results from SPRINTER Peer Reviewed.... So clearly
RM and the team see them as significant... So do BP by the look of those who lined up at IDWeek
to listen to our presentation.... But hey Ghia's friend says nothing to see here..... Let's
stick to what we know shall we......!!!
GHIA
JUST POINTING OUT YOU MAKE THINGS UP.... I AM NOT THE ONLY ONE WHO HAS POSTED THAT..
I SEE CAPITALS LIKE THE HEADLINES OF A NEWSPAPER... YOU WANT READERS TO SEE THEM...
How long should it take to analyse the LC data?
There she blows!!
If a group of PI’s club together and use their effective share holding as leverage to open dialogue with a company you may be surprised that they listen.
If you then appoint appropriate spokespeople and infrequently pester them again you will be surprised at the response.
When this particular poster suggests they have had dialogue with RM I believe them as in the past as a collective we have had dialogue with the company and this has been referenced in company statements.
Before anyone suggests the notion of insider trading this is not what is being suggested.
For a long time Mani has been ramping Long Covid it’s time to challenge that and ask them to justify how and why they believe this adds value in the short to medium term and how it would change the way SNG would be trialled.
Ordered a book by Robbie Burns called The Naked Trader. Hoping to get #inspired
I wonder if there is a section on stock forums too?!